Magnetic resonance imaging of diffuse liver diseases

Topics in Magnetic Resonance Imaging

Volumn 13, Issue 3, 2002, Pages 151-164

  Martin, Diego R ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cirrhosis; Hemochromatosis; Hepatitis; Liver; Magnetic resonance imaging

Indexed keywords

CELL MARKER; IRON; LIPID;

BLEEDING; BLOOD VESSEL OCCLUSION; CLINICAL FEATURE; CONTRAST ENHANCEMENT; EVALUATION; FIBROSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; INFARCTION; INFLAMMATION; IRON TRANSPORT; LIPID METABOLISM; LIVER DISEASE; LIVER PERFUSION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SOFT TISSUE; STAINING;

ADULT; AGED; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMOCHROMATOSIS; HEPATITIS; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 0036621061     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002142-200206000-00003     Document Type: Review

References (49)

1. Semelka RC, Martin DR, Balci C, et al. Focal liver lesions: Comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 2001;13:397-401.
2. Martin DR, Semelka RC. Imaging of benign and malignant focal liver lesions. Magn Reson Imaging Clin N Am 2001;9:785-802, vi-vii.
3. Semelka RC, Worawattanakul S, Kelekis NL, et al. Liver lesion detection, characterization, and effect on patient management: comparison of single-phase spiral CT and current MR techniques. J Magn Reson Imaging 1997;7:1040-1047.
4. Siegelman ES. MR imaging of diffuse liver disease. Hepatic fat and iron. Magn Reson Imaging Clin N Am 1997;5:347-365.
5. Pope C, Gore J, Sostman D, et al. Diffuse fatty infiltration of the liver by magnetic resonance. Magn Reson Imaging 1986;4:267-270.
6. Levenson H, Greensite F, Hoefs J, et al. Fatty infiltration of the liver: Quantification with phase-contrast MR imaging at 1.5 T vs biopsy. AJR Am J Roentgenol 1991;156:307-312.
7. Thu HD, Mathieu D, Thu NT, et al. Value of MR imaging in evaluating focal fatty infiltration of the liver: Preliminary study. Radiographics 1991;11:1003-1012.
8. Kreft BP, Tanimoto A, Baba Y, et al. Diagnosis of fatty liver with MR imaging. J Magn Reson Imaging 1992;2:463-471.
9. Rofsky NM, Weinreb JC, Ambrosino MM, et al. Comparison between in-phase and opposed-phase T1-weighted breath-hold FLASH sequences for hepatic imaging. J Comput Assist Tomogr 1996;20:230-235.
10. Kier R, Mason BJ. Water-suppressed MR imaging of focal fatty infiltration of the liver. Radiology 1997;203:575-577.
11. Mitchell DG. Focal manifestations of diffuse liver disease at MR imaging. Radiology 1992;185:1-11.
12. Mitchell DG. Chemical shift magnetic resonance imaging: Applications in the abdomen and pelvis. Top Magn Reson Imaging 1992;4:46-63.
13. Semelka RC, Shoenut JP, Kroeker MA, et al. Focal liver disease: Comparison of dynamic contrast-enhanced CT and T2-weighted fatsuppressed, FLASH, and dynamic gadolinium-enhanced MR imaging at 1.5 T. Radiology 1992;184:687-694.
14. Johnson CD. Magnetic resonance imaging of the liver: Current clinical applications. Mayo Clin Proc 1993;68:147-156.
15. Verhille R, Marchal G, Baert AL, et al. Focal fatty infiltration of the liver associated with important mass effect. J Belge Radiol 1994;77:10-12.
16. Rofsky NM, Fleishaker H. CT and MRI of diffuse liver disease. Semin Ultrasound CT MR 1995;16:16-33.
17. Kroncke TJ, Taupitz M, Kivelitz D, et al. Multifocal nodular fatty infiltration of the liver mimicking metastatic disease on CT: Imaging findings and diagnosis using MR imaging. Eur Radiol 2000;10:1095-1100.
18. Siegelman ES, Mitchell DG, Rubin R, et al. Parenchymal versus reticuloendothelial iron overload in the liver: Distinction with MR imaging. Radiology 1991;179:361-366.
19. Siegelman ES, Mitchell DG, Semelka RC. Abdominal iron deposition: Metabolism, MR findings, and clinical importance. Radiology 1996;199:13-22.
20. Guyader D, Gandon Y. Quantification of iron overload. Bull Acad Natl Med 2000;184:337-347.
21. Johnston DL, Rice L, Vick GW 3rd, et al. Assessment of tissue iron overload by nuclear magnetic resonance imaging. Am J Med 1989;87:40-47.
22. Kinney TB, Deluca SA. Idiopathic hemochromatosis. Am Fam Physician 1991;44:873-875.
23. Siegelman ES, Mitchell DG, Outwater E, et al. Idiopathic hemochromatosis: MR imaging findings in cirrhotic and precirrhotic patients. Radiology 1993;188:637-641.
24. Thomsen C, Wiggers P, Ring-Larsen H, et al. Identification of patients with hereditary haemochromatosis by magnetic resonance imaging and spectroscopic relaxation time measurements. Magn Reson Imaging 1992;10:867-879.
25. Kim IY, Mitchell DG, Vinitski S, et al. MR imaging of hepatic iron overload in rat. J Magn Reson Imaging 1993;3:67-70.
26. Mitchell DG. Hepatic imaging: Techniques and unique applications of magnetic resonance imaging. Magn Reson Q 1993;9:84-112.
27. Engelhardt R, Langkowski JH, Fischer R, et al. Liver iron quantification: Studies in aqueous iron solutions, iron overloaded rats, and patients with hereditary hemochromatosis. Magn Reson Imaging 1994;12:999-1007.
28. Gandon Y, Guyader D, Heautot JF, et al. Hemochromatosis: Diagnosis and quantification of liver iron with gradient-echo MR imaging. Radiology 1994;193:533-538.
29. Keevil SF, Alstead EM, Dolke G, et al. Non-invasive assessment of diffuse liver disease by in vivo measurement of proton nuclear magnetic resonance relaxation times at 0.08 T. Br J Radiol 1994;67:1083-1087.
30. Bonetti MG, Castriota-Scanderbeg A, Criconia GM, et al. Hepatic iron overload in thalassemic patients: Proposal and validation of an MRI method of assessment. Pediatr Radiol 1996;26:650-656.
31. Bulte JW, Miller GF, Vymazal J, et al. Hepatic hemosiderosis in non-human primates: Quantification of liver iron using different field strengths. Magn Reson Med 1997;37:530-536.
32. Ernst O, Sergent G, Bonvarlet P, et al. Hepatic iron overload: Diagnosis and quantification with MR imaging. AJR Am J Roentgenol 1997;168:1205-1208.
33. Kreeftenberg HG Jr, Mooyaart EL, Huizenga JR, et al. Quantification of liver iron concentration with magnetic resonance imaging by combining T1-, T2-weighted spin echo sequences and a gradient echo sequence. Neth J Med 2000;56:133-137.
34. Semelka RC, Chung JJ, Hussain SM, et al. Chronic hepatitis: correlation of early patchy and late linear enhancement patterns on gadolinium-enhanced MR images with histopathology initial experience. J Magn Reson Imaging 2001;13:385-391.
35. Matsui O, Kadoya M, Takashima T, et al. Intrahepatic periportal abnormal intensity on MR images: An indication of various hepatobiliary diseases. Radiology 1989;171:335-338.
36. Marzola P, Maggioni F, Vicinanza E, et al. Evaluation of the hepatocyte-specific contrast agent gadobenate dimeglumine for MR imaging of acute hepatitis in a rat model. J Magn Reson Imaging 1997;7:147-152.
37. Kreft B, Dombrowski F, Block W, et al. Evaluation of different models of experimentally induced liver cirrhosis for MRI research with correlation to histopathologic findings. Invest Radiol 1999;34:360-366.
38. Murakami T, Kim T, Nakamura H. Hepatitis, cirrhosis, and hepatoma. J Magn Reson Imaging 1998;8:346-358.
39. Martin DR, Yang M, Thomasson DT, et al. MR imaging of acute hepatitis: Sensitive detection based on breath-hold T1 weighted spoiled gradient echo gadolinium dynamically enhanced images. ISMRM 2002;A1964.
40. Mergo PJ, Ros PR. Imaging of diffuse liver disease. Radiol Clin North Am 1998;36:365-375.
41. Baban NK, Hubbs DT, Roy TM. Wilson's disease. South Med J 1997;90:535-538.
42. Van Beers B, Trigaux JP, Grandin C, et al. Regenerative nodules in hepatic cirrhosis. Value of gradient-echo MR imaging with a surface coil. Acta Radiol 1992;33:245-250.
43. Elizondo G, Weissleder R, Stark DD, et al. Hepatic cirrhosis and hepatitis: MR imaging enhanced with superparamagnetic iron oxide. Radiology 1990;174:797-801.
44. King LJ, Scurr ED, Murugan N, et al. Hepatobiliary and pancreatic manifestations of cystic fibrosis: MR imaging appearances. Radiographics 2000;20:767-777.
45. Koolpe HA, Koolpe L. Portal hypertension: Angiographic and hemodynamic evaluation. Radiol Clin North Am 1986;24:369-381.
46. Noone TC, Semelka RC, Woosley JT, et al. Ultrasound and MR findings in acute Budd-Chiari syndrome with histopathologic correlation. J Comput Assist Tomogr 1996;20:819-822.
47. Noone TC, Semelka RC, Siegelman ES, et al. Budd-Chiari syndrome: Spectrum of appearances of acute, subacute, and chronic disease with magnetic resonance imaging. J Magn Reson Imaging 2000;11:44-50.
48. Rooholamini SA, Au AH, Hansen GC, et al. Imaging of pregnancy-related complications. Radiographics 1993;13:753-770.
49. Zissin R, Yaffe D, Fejgin M, et al. Hepatic infarction in preeclampsia as part of the HELLP syndrome: CT appearance. Abdom Imaging 1999;24:594-596.